WATERTOWN, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer, today announced that two posters will be presented at the upcoming Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting, taking place November 6-10, 2024, in Houston, Texas. Details for the ...

NEEDHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present a poster at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting taking place November 6-10, 2024 in Houston, Texas and virtually. Presentation details are as follows: Title: Therapeutic potential of CAN-3 ...

NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced two abstracts accepted for poster presentation at the Society for Immunotherapy of Cancer's 39th Annual Meeting (SITC 2024) taking place taking place in Houston, Texas on November 8-10, 2024. The first abstract accepted for poster presentation contains updated and expanded ...

Core Insights - Lyell Immunopharma, Inc. announced the acceptance of three abstracts for presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) from Nov. 6-10, 2024, in Houston, TX, focusing on its pipeline of cell therapies and anti-exhaustion technology [1][2][4] Group 1: Clinical Trials and Presentations - The first presentation will showcase translational data from the LYL797 Phase 1 clinical trial, highlighting solid tumor infiltration and cell killing by reprogrammed ROR1 CAR T cells [2] - The second presentation will discuss multiomic profiling of LYL119, a reprogrammed ROR1 CAR T product, which generates T cells with reduced exhaustion and enhanced memory characteristics [3] - The third presentation will focus on utilizing Stim-R™ Technology to reduce irradiated feeder cells in the tumor-infiltrating lymphocyte culture process [3] Group 2: Company Overview - Lyell is a clinical-stage T-cell reprogramming company with a diverse pipeline of cell therapies, including three product candidates in or entering Phase 1 clinical development for solid tumors and hematologic malignancies [4] - The company employs novel anti-exhaustion technology to address barriers such as T-cell exhaustion and lack of durable stemness, aiming for improved clinical outcomes [4] - Lyell is based in South San Francisco, California, with additional facilities in Seattle and Bothell, Washington [4]

PHILADELPHIA and VANCOUVER, British Columbia, Sept. 09, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces a poster presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, held November 6-10, 2024, in Houston, TX. "We are thrilled to be invited to present our data at this prestigious conference," stated Mi ...

Financial Data and Key Metrics Changes - The company reported nearly $1 billion in transactions for the quarter and repurchased or retired over $50 million in debt [2][7] - Total NOI for the Curbline portfolio is expected to be approximately $84 million in 2024, up from $79 million previously projected [20] - Same-store NOI for the Curbline portfolio is anticipated to average greater than 3% for the next three years [5][20] Business Line Data and Key Metrics Changes - The Curbline portfolio includes 72 wholly-owned convenience properties, totaling 2.4 million square feet, expected to generate about $84 million of NOI [6] - Leasing activity for Curbline has shown strong momentum, with nearly 50% straight-line new leasing rent spreads for the trailing 12-month period [149] - The company acquired five convenience properties in the second quarter for a total of $65 million, with additional acquisitions of $27 million in the third quarter [14] Market Data and Key Metrics Changes - The company noted that same-store NOI growth is expected to be between 3.5% and 5.5% for 2024, reflecting strong demand in the convenience sector [20][90] - The Curbline portfolio is expected to capture growing market rents with minimal landlord capital due to high tenant retention [5][27] Company Strategy and Development Direction - The planned spin-off of the Convenience portfolio into Curbline Properties is set for October 1, 2024, with Curbline expected to have no debt and $600 million in cash [7][22] - SITE Centers will focus on a diversified portfolio post-spin, including assets in major markets with strong tenant sales [9][11] - The company aims to maximize value for stakeholders through continued leasing and asset management while remaining flexible to market signals [11][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the capital efficiency of the business, which has become increasingly important as capital costs rise [4] - The company remains optimistic about the unique opportunities in the convenience subsector, highlighting a significant growth potential [27] - Management noted that leasing demand remains steady from both existing retailers and new concepts entering suburban markets [15][19] Other Important Information - The company has closed $951 million in wholly-owned property sales year-to-date, with total dispositions since July 1, 2023, exceeding $1.8 billion at a blended cap rate of 7.1% [8] - The balance sheet is positioned to support both SITE and Curbline's business plans, with significant cash reserves and no outstanding debt for Curbline [22][153] Q&A Session Summary Question: What is the timing for the Form 10? - Management expects it to be released sometime in September [30] Question: Can you explain the recent cap rate trends? - The increase in cap rates is attributed to higher leasing activity, with a caution that the small denominator can lead to volatility [25] Question: What is the expected mix of tenants in the Curbline portfolio? - The focus is on maintaining a balance between credit and growth, with a significant portion of the portfolio occupied by high credit tenants [134] Question: How does the company view the current leasing environment? - Management noted strong demand for convenience properties, with a high occupancy rate expected to remain stable [162] Question: What is the expected impact of economic cycles on the portfolio? - The portfolio is well-positioned to withstand economic downturns, with a high percentage of national tenants mitigating risks [170]

For the quarter ended June 2024, SITE CENTERS CORP. (SITC) reported revenue of $114.13 million, down 16.3% over the same period last year. EPS came in at $0.27, compared to $0.01 in the year-ago quarter. The reported revenue represents a surprise of -0.50% over the Zacks Consensus Estimate of $114.7 million. With the consensus EPS estimate being $0.24, the EPS surprise was +12.50%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wal ...

SITE CENTERS CORP. (SITC) came out with quarterly funds from operations (FFO) of $0.27 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to FFO of $0.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an FFO surprise of 12.50%. A quarter ago, it was expected that this company would post FFO of $0.24 per share when it actually produced FFO of $0.28, delivering a surprise of 16.67%. Over the last four quarters, the comp ...

Quarterly Financial Supplement RECENT ACQUISITION CROCKER COMMONS WESTLAKE, OHIO 上 Nigal Cre SITC LISTED NYSE SITE CENTERS COMPANY & PORTFOLIO OVERVIEW PORTFOLIO COMPOSITION 101 93.2% GRI G R B SITE Centers Corp. Table of Contents Company Summary Portfolio Summary 10 Capital Structure 11 Same Store Metrics 12 Leasing Summary 13-14 Lease Expirations 15 Top 50 Tenants 16 Shopping Center Summary Property List 25-27 S l E T FOR THE PERIOD ENDED JUNE 30, 2024 Exhibit 99.1 The Company is a self-administered and s ...

SITE Centers Corp's (SITC) well-located portfolio of retail real estate assets concentrated mostly in the suburban and high household income regions positions it well for growth. Its focus on the aggressive capitalrecycling program also augurs well. However, rising e-commerce adoption and elevated interest rates add to its woes. This retail real estate investment trust's (REIT) aggressive capital-recycling program highlights its prudent capital-management practices and helps preserve balance sheet strength. ...